Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
European Journal of Pharmacology
|
May 12, 2006
Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys
Ken Kitayama, Daisuke Nakai, Keita Kono, et al.
Blood
|
October 31, 2007
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice
Pascale V Guillot, Oyebode Abass, J H Duncan Bassett, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2009
Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats
Yoshikazu Uto, Tsuneaki Ogata, Yohei Kiyotsuka, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine]
Yoshikazu Uto, Yohei Kiyotsuka, Yuko Ueno, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation
Yoshikazu Uto, Tsuneaki Ogata, Yohei Kiyotsuka, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide
Yoshikazu Uto, Tsuneaki Ogata, Jun Harada, et al.
BMJ Open Gastroenterology
|
November 14, 2023
COVID-19 severity is associated with the risk of gastrointestinal bleeding
Shuji Hibiya, Takashi Fujii, Toshimitsu Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 29, 2024
High serum gamma-glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma
Miyako Murakawa, Mina Nakagawa, Hisaaki Nishimura, et al.
Cancer Medicine
|
August 26, 2025
Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real-World Clinical Study
Shun Kaneko, Yasuhiro Asahina, Miyako Murakawa, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
European Journal of Pharmacology
|
May 12, 2006
Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys
Ken Kitayama, Daisuke Nakai, Keita Kono, et al.
Blood
|
October 31, 2007
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice
Pascale V Guillot, Oyebode Abass, J H Duncan Bassett, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2009
Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats
Yoshikazu Uto, Tsuneaki Ogata, Yohei Kiyotsuka, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine]
Yoshikazu Uto, Yohei Kiyotsuka, Yuko Ueno, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation
Yoshikazu Uto, Tsuneaki Ogata, Yohei Kiyotsuka, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide
Yoshikazu Uto, Tsuneaki Ogata, Jun Harada, et al.
BMJ Open Gastroenterology
|
November 14, 2023
COVID-19 severity is associated with the risk of gastrointestinal bleeding
Shuji Hibiya, Takashi Fujii, Toshimitsu Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 29, 2024
High serum gamma-glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma
Miyako Murakawa, Mina Nakagawa, Hisaaki Nishimura, et al.
Cancer Medicine
|
August 26, 2025
Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real-World Clinical Study
Shun Kaneko, Yasuhiro Asahina, Miyako Murakawa, et al.
Page
of 3